Design of Clinical Trials for Mild to Moderate Crohn's Disease

Gastroenterology. 2022 Jun;162(7):1800-1814.e1. doi: 10.1053/j.gastro.2022.02.036. Epub 2022 Feb 28.
No abstract available

MeSH terms

  • Budesonide / therapeutic use
  • Crohn Disease* / diagnosis
  • Crohn Disease* / drug therapy
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Remission Induction

Substances

  • Gastrointestinal Agents
  • Budesonide